Although SCAD causes a small percentage of heart attacks overall, it’s responsible for 40% of heart attacks in women under the age of 50.
From: https://www.webmd.com/heart-disease/news/20180319/scad-heart-attack-strikes-young-women?src=RSS_PUBLIC
Find information about health and nutrition from various and reliable sources all over the world, in just one site. World's latest headlines all in one place.
Although SCAD causes a small percentage of heart attacks overall, it’s responsible for 40% of heart attacks in women under the age of 50.
The incident occurred overnight, but police did not say whether it was late Sunday or early Monday and did not release any details about the woman.
The treatment involves using cancer drugs to decimate a patient's immune system and then restarting it with a stem cell transplant, BBC News reported.
Prior research has shown that kids with severe head injuries are more likely to have attention problems following their injury. In fact, ADHD is the most common psychiatric disorder among children with a history of serious brain injury.
In a four-week trial of men under 50, an experimental hormone-based birth control pill was found to be "well-tolerated."
Riding with a marijuana-impaired driver was more common than riding with an alcohol-impaired driver, researchers found.
The problem was discovered when the Sheboygan Falls, WI, company received three complaints that sausages were found to have pieces of hard, green plastic.
A survey of 1,000 practicing physicians by the American Medical Association (AMA) found that doctors believe these prior authorizations affect clinical outcomes for 9 of 10 patients.
More than 14 percent of the veterans developed high blood pressure at least 90 days after being wounded.
A study of nearly 5,200 Italian men found that those with low sperm counts were 1.2 times more likely to have more body fat, higher blood pressure, higher bad cholesterol and triglycerides, and lower levels of good cholesterol.
Among teenagers and young adults diagnosed with a "self-harm" injury, the risk of suicide in the next year was nearly 27 times higher than the U.S. norm, researchers found.
Diverse clinical trials help will help researchers create treatments that benefit all Americans.
Clinical trials help doctors create new and better cancer treatments.
Follow me on Twitter @1111linno
My life is extraordinary. Such a hyperbolic-sounding statement and yet, in so many ways, so very true.
Extraordinary because a decade ago I was told I had three to five months left to live. Diagnosed with non-small cell lung cancer (NSCLC) three years earlier, the removal of most of my left lung followed by chemotherapy had done little to slow down the cancer. Too diffuse for radiation, we had run out of options.
And so, I did what the dying do. Grieving as preparations began. I bid adieu to friends and family, held my children even closer, and sought the help of a thoracic social worker. The day I walked through her door, my first words were, “I need you to help me learn how to die.”
Life can be so strange, so surprising. I never thought I’d be diagnosed with lung cancer at the age of 45 and that I’d be facing death at 48. But the biggest surprise was yet to come.
Obviously, I didn’t die. Just in the nick of time, medical science intervened as I was found to have a newly identified driver in lung cancer, an ALK (anaplastic lymphoma kinase) mutation. On October 1, 2008 I became the fourth person in the world with NSCLC to enroll in a first in-human trial targeting ALK. And, to all of our surprise, I had an amazing response.
In the years hence, I have returned to chemotherapy, but also enrolled in two more phase I clinical trials. And life has gone on. My youngest child was only seven when I was diagnosed; two years ago I had the immense privilege of seeing him graduate cum laude from Phillips Exeter Academy. He is now in his second year at MIT and my other two adult children are thriving in both their relationships and careers.
Four years ago, my own marriage ended, in no small part because of the differences in the way we approached my cancer, which, though still considered terminal, had also become a chronic illness.
Living alone has had its challenges, but I can truly say that I have never been happier. For the first time since my early 20s, I am focusing on my own goals. Upon leaving our marriage, I moved to a converted mill housing a community of creatives. I call it the art dorm, and my loft — the art fort. I recently had my first solo art show, and it was a big success. It is safe to say I’m on a creative roll. I am also working on a book (or two), a DIY MFA (that’s another blog), and I devote more time than ever to patient advocacy, with a focus on clinical trial participation and medical research.
Last year a little white Shiba Inu came into my life — a rescue that I actually helped rescue — and we walk several miles every day. Five months ago I also started online dating and, contrary to the experience of many, I’m having a blast. I attribute that to my extraordinary (yes) self-confidence and my willingness to go all in, without regard to being hurt. These are qualities that I did not possess prior to my diagnosis with cancer.
It’s such an odd and unexpected paradigm — living with a terminal illness. The downsides are obvious and yet, I have learned so very much. Forced to face my greatest fears, I have become far more courageous; in fact, there is little I fear now. This means my anxiety has gone way, way down and my ability to enjoy life, way, way up. Because I have learned to sit with uncertainty, I am no longer married to outcomes. It’s all good. I liken this to loving/living life unconditionally; I simply cannot be disappointed. Each new morning is opened like a present — a gift I simply did not expect to receive.
Perhaps it is this awareness that has sharpened both my perception and my appreciation; I refuse to waste a moment. And although I would prefer to not have an illness that is terminal, I would wager that I am infinitely more alive than many who do not.
The post When dying is a rebirth appeared first on Harvard Health Blog.